Acer Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Acer Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2023.
  • Acer Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$12.9M, a 146% decline year-over-year.
  • Acer Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$27.4M, a 15.4% decline year-over-year.
  • Acer Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$24.6M, a 54.3% decline from 2021.
  • Acer Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$15.9M, a 30.1% increase from 2020.
  • Acer Therapeutics Inc. annual Operating Income (Loss) for 2020 was -$22.8M, a 23.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$27.4M -$12.9M -$7.64M -146% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$19.8M -$4.29M +$2.77M +39.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$22.6M -$4.99M +$2.06M +29.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$24.6M -$5.26M -$843K -19.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 -$23.8M -$5.24M -$1.96M -59.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$21.8M -$7.06M -$3.44M -94.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$18.4M -$7.05M -$2.43M -52.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$15.9M -$4.42M +$1.75M +28.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$17.7M -$3.28M +$2.61M +44.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$20.3M -$3.63M +$2.14M +37.1% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-14
Q1 2021 -$22.5M -$4.62M +$351K +7.07% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$22.8M -$6.17M -$980K -18.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 -$21.8M -$5.89M -$527K -9.82% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 -$21.3M -$5.77M +$5.4M +48.3% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-11-19
Q1 2020 -$26.7M -$4.97M +$3.21M +39.2% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-11-19
Q4 2019 -$29.9M -$5.19M +$3.51M +40.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$33.4M -$5.36M -$1.26M -30.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$32.1M -$11.2M -$6.25M -127% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$25.9M -$8.18M -$4.19M -105% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$21.7M -$8.7M -$4.49M -107% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$17.2M -$4.11M -$748K -22.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$16.5M -$4.92M -$1.9M -63.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$14.6M -$3.99M -$624K -18.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$13.9M -$4.21M +$108K +2.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$14.1M -$3.36M -$5.25M -278% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$8.81M -$3.01M -$906K -43% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$7.9M -$3.37M -$1.2M -55.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$6.7M -$4.31M -$1.2M -38.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$5.5M $1.89M +$4.69M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$10.2M -$2.11M +$700K +24.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$10.9M -$2.16M +$1.2M +35.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$12.1M -$3.12M +$244K +7.26% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 -$12.3M -$2.81M +$1.07M +27.6% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-10
Q2 2015 -$13.4M -$2.81M +$1.36M +32.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-11-14
Q1 2015 -$14.8M -$3.36M +$298K +8.14% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$15.1M -$3.36M +$405K +10.8% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$15.5M -$3.88M -$1.02M -35.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$14.5M -$4.17M -$1.45M -53.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$13M -$3.66M -$1.08M -41.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$11.9M -$3.76M -$1.24M -49% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-23
Q3 2013 -$10.7M -$2.86M -$793K -38.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$9.89M -$2.71M -$549K -25.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$9.34M -$2.58M -$208K -8.78% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$9.13M -$2.53M -$649K -34.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-27
Q3 2012 -$8.48M -$2.07M -$773K -59.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$7.71M -$2.16M -$678K -45.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$7.03M -$2.37M -$1.07M -81.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$5.97M -$1.88M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$1.3M -$7.24K -0.56% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$1.49M -$56.5K -3.95% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$1.31M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$1.29M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$1.43M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.